Tabell 1 (biverkningaroch laboratorieavvikelser med incidenser ≥ 10% och respektive incidens med placebo; signifikant associerade biverkningar < 10%) ###>23 Table 1 (adverse events and laboratory abnormalities with incidence rates ≥ 10% and the respective percentages under placebo; significantly associated side effects < 10%).